Saiyin, T.; Christou, G.; Sabloff, M.; Crosbie, T.; Nguyen-Tham, K.-M.; Fulcher, J.
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective. Curr. Oncol. 2025, 32, 213.
https://doi.org/10.3390/curroncol32040213
AMA Style
Saiyin T, Christou G, Sabloff M, Crosbie T, Nguyen-Tham K-M, Fulcher J.
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective. Current Oncology. 2025; 32(4):213.
https://doi.org/10.3390/curroncol32040213
Chicago/Turabian Style
Saiyin, Tana, Grace Christou, Mitchell Sabloff, Tina Crosbie, Kim-My Nguyen-Tham, and Jill Fulcher.
2025. "Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective" Current Oncology 32, no. 4: 213.
https://doi.org/10.3390/curroncol32040213
APA Style
Saiyin, T., Christou, G., Sabloff, M., Crosbie, T., Nguyen-Tham, K.-M., & Fulcher, J.
(2025). Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective. Current Oncology, 32(4), 213.
https://doi.org/10.3390/curroncol32040213
